Borage, Evening Primrose, Blackcurrant, and Fungal Oils; γ-Linolenic Acid-rich Oils

Gourmet and Health-Promoting Specialty Oils

Volumn , Issue , 2009, Pages 237-266

  Barre, D E ^a  

^a CAPE BRETON UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882103206     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-893997-97-4.50013-9     Document Type: Chapter

References (172)

1. Abraham R.D., Riermersma R.A., Elton R.A., Macintyre C., Oliver M.F. Effects of safflower oil and evening primrose oil in men with a low dihomo-γ-linolenic acid. Atherosclerosis 1990, 81:199-208.
2. Agostoni C., Riva E., Biasucci G., Luotti D., Bruzzese M.G., Marangoni F., Giovannini M. The effects of n-3 and n-6 polyunsaturated fatty acids on plasma lipids and fatty acids of treated phenylketonuric children. Prostaglandins Leukot. Essent. Fatty Acids 1995, 53:401-404.
3. Andreassi M., Forleo P., Di Lorio A., Masci S., Abate G., Amerio P. Efficacy of γ-linolenic acid in the treatment of patients with atopic dermatitis. J. Int. Med. Res. 1997, 25:266-274.
4. Anstey A., Quigley M., Wilkinson J.D. Topical evening primrose oil as a treatment for atopic eczema. J. Dermatol. Res. 1990, 1:199-201.
5. Arimura T., Kojima-Yuasa A., Suzuki M., Kennedy D.O., Matsui-Yuasa I. Caspase-independent apoptosis induced by evening primrose extract in Ehrlich ascites tumor cells. Cancer Letters 2003, 201:9-16.
6. Arimura T., Kojima-Yuasa A., Tatsumi Y., Kennedy D.O., Matsui-Yuasa I. Involvment of polyamines in evening primrose extract-induced apoptosis in Erlich ascites tumor cells. Amino Acids 2005, 28:21-27.
7. Auestad N., Halter R., Hall R.T., Blatter M., Bogle M.L., Burks W., Erickson J.R., Fitzgerald K.M., Dobson V., Innis S.M., et al. Growth development in term infants fed long-chain polyunsaturated fatty acids: A double-masked, randomized, parallel, prospective, multivariate study. Pediatrics. 2001, 108:372-381.
8. Bahmer F.A. ADASI Score: Atopic dermatitis area and severity index. Acta Derm. Venereol. Suppl.(Stockh.) 1992, 176:32-33.
9. Bamford J.T.M., Gibson R.W., Renier C.M. Atopic eczema unresponsive to evening primrose oil (linoleic and γ-linolenic). J. Am. Acad. Dermatol. 1985, 13:959-965.
10. Bard J.M., Luc G., Jude B., Bordet J.C., Lacroix B., Bonte J.P., Parra H.J., Duriez P. A therapeutic dosage (3 g/day) of borage oil supplementation has no effect on platelet aggregation in healthy volunteers. Fundam. Clin. Pharmacol. 1997, 11:143-144.
11. Barre D.E., Holub B.J. The effect of borage oil consumption on the composition of individual phospholipids in human platelets. Lipids 1992, 27:315-320.
12. Barre D.E., Holub B.J. The effect of borage oil consumption on human plasma lipid levels and the phosphatidylcholine and cholesterol ester composition of high density lipoprotein. Nutr. Res. 1992, 12:1181-1194.
13. 2 formation. Nutr. Res. 1993, 13:739-751.
14. Beaubaire N.A., Simon J.E. Production potential of Borago officinalis L. Acta Hort. 1987, 208:101-114.
15. Belch J.J.F., Ansell D., Madhok R., O'Dowd A., Sturrock R.D. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: A double-blind placebo controlled study. Ann. Rheum. Dis. 1988, 47:96-104.
16. Belch J.J.F., Hill A. Evening primrose oil and borage oil in rheumatologic conditions. Am. J. Clin. Nutr. 2000, 71(suppl.):352S-356S.
17. Bergstrom, J.D. Is squalene synthase a good target for cholesterol lowering therapy? Studies with zaragozic acids (abstract). Drugs Affecting Lipid Metabolism Conference Houston, 1995, 6.
18. Berth-Jones J., Graham-Brown R.A.C. Placebo controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993, 341:1557-1560.
19. Biagi P.L., Bordoni A., Hrelia S., Celadon M., Ricci G.P., Cannella V., Patrizi A., Specchia F., Masi M. The effect of gamma-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitis. Drugs Exp. Clin. Res. 1994, 20:77-84.
20. Biagi P.L., Bordoni A., Masi M., Ricci G., Fanelli C., Patrizi A., Ceccolini E. A long-term study on the use of evening primrose oil (Efamol) in atopic children. Drugs Exp. Clin. Res. 1988, 14:285-290.
21. Birch A.E., Fenner G.P., Watkins R., Boyd L.C. Antioxidant properties of evening primrose seed extracts. J. Agric Food Chem. 2001, 49:4502-4507.
22. Boberg M., Vessby B., Selinius I. Effects of dietary supplementation with n-6 and n-3 long chain polyunsaturated fatty acids on serum lipoproteins and platelet function in hypertriglyceridaemic patients. Acta. Med. Scand. 1986, 220:153-160.
23. Boon H., Wong J. Botanical medicine and cancer: A review of safety and efficacy. Expert Opin. Pharmacother. 2004, 5:2485-2501.
24. Bordoni A., Biagi P.L., Masi M., Ricci G., Fanelli C., Patrizi A., Ceccolini E. Evening primrose oil (Efamol) in the treatment of children with atopic eczema. Drugs Exp. Clin. Res. 1987, 14:291-297.
25. Brush M.G., Watson S.J., Horrobin D.F., Manku M.S. Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome. Am. J. Obstet. Gynecol. 1984, 150:363-366.
26. Brzeski M., Madhok R., Capell H.A. Evening primrose oil in patients with rheumatoid arthritis and side-effects of non-steroidal anti-inflammatory drugs. Br. J. Rheumatol . 1991, 30:370-372.
27. Budeiri D., Li Wan Po A., Dornan J.C. Is evening primrose oil of value in the treatment of premenstrual syndrome??. Control Clin. Trials 1996, 17:60-68.
28. Burns R.A., Wibert G.J., Diersen-Schade D.A., Kelly C.M. Evaluation of single-cell sources of docosahexaenoic acid and arachidonic acid: 3-month rat oral safety study with an in utero phase. Food and Chem. Toxicol. 1999, 37:23-36.
29. Cai J., Jiang W.G., Mansel R.E. Inhibition of angiogenic factor-and tumour-induced angiogenesis by gamma-linolenic acid. Prostaglandins Leukot. Essent. Fatty Acids 1999, 60:21-29.
30. Cameron N.E., Cotter M.A. Comparison of the effects of ascorbyl γ-linolenic acid and γ-linolenic acid in the correction of neurovascular deficits in diabetic rats. Diabetologica 1996, 39:1047-1054.
31. Cameron N.E., Cotter M.A. Interaction between oxidative stress and γ-linolenic acid in impaired neurovascular function of diabetic rats. Am. J. Physiol. 1996, 271:E471-E476.
32. Cameron N.E., Cotter M.A., Horrobin D.F., Tritschler H.J. Effects of α-lipoic acid on neurovascular function in diabetic rats: Interaction with essential fatty acids. Diabetologica 1998, 41:390-399.
33. Carroll D.G. Nonhormonal therapies for hot flashes in menopause. Am. Fam. Physician 2006, 73:457-464.
34. Cerda-Olmedo E., Avalos J. Oleaginous fungi: Carotene-rich oil from phycomyces. Prog Lipid Res. 1994, 33:185-192.
35. 2 extraction of fungal oil containing γ-linolenic acid. Biotech. Techniques. 1999, 13:11-15.
36. Chaintreuil J., Monnier L., Colette C., Crastes de Paulet P., Orsetti A., Spielmann D., Mendy F., Crastes de Paulet A. Effects of dietary γ-linolenate supplementation on serum lipids and platelet function in insulin dependent diabetic patients. Hum. Nutr. Clin. Nutr. 1984, 38:121-130.
37. Chung S., Kong S., Seong K., Cho Y. γ-linolenic acid in borage oil reverses epidermal hyperproliferation in guinea pigs. J. Nutr. 2002, 132:3090-3097.
38. Clandinin M.T., van Aerde J.E., Merkel K.L., Harris C.L., Springer M.A., Hansen J.W., Diersen-Schade D.A. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J. Pediatr. 2005, 146:461-468.
39. Corbett R., Meagher J.B.A., Leonard B.E. The effect of acute alcohol intoxication on psychometric testing and 5-HT-induced platelet aggregation in normal subjects; modulatory role of evening primrose oil. Hum. Psychopharm. 1991, 6:253-256.
40. Corrigan F.M., Horrobin D.F., Skinner E.T., Besson J.A.O., Cooper M.B. Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimers' disease patients and its relationship to acetyl CoA content. Int. J. Biochem. Cell Biol. 1998, 30:197-207.
41. + ATPase activity and membrane fatty acid composition in sciatic nerve of diabetic rats. J. Nutr. Biochem. 1999, 10:411-420.
42. Cunnane S.C. The Canadian Society for Nutritional Sciences 1995 Young Scientist Award Lecture. Recent studies on the syntheis, β-oxidation, and deficiency on linoleate and alpha-linoleate: Are essential fatty acids more aptly named indispensable or conditionally dispensable fatty acids??. Can. J. Physiol. Pharmacol. 1996, 74:629-639.
43. Darcet P., Driss F., Mendy F., Delhaye N. Exploration du metabolism des acides gras des lipids totaux plasmatiques et de l'aggregation plaquettaire d'une population d'hommes ages a l'aide d'une alimentation enrichie en acide y-linolenique. Ann. Nutr. Aliment. 1980, 34:277-290.
44. Darlington L.G., Stone T.W. Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Brit. J. Nutr. 2001, 85:251-269.
45. Das U.N., Prasad V.V.S.K., Reddy D.R. Local application of a γ linolenic acid in the treatment of human gliomas. Cancer Lett. 1995, 94:147-155.
46. de la Puerta Vázquez R., Martínez-Domínguez E., Perona J.S., Ruiz-Gutiérrez V. Effects of different dietary oils on inflammatory mediator generation and fatty acid composition in rat neutrophils. Metabolism 2004, 53:59-65.
47. Deferne J.-L., Leeds A.R. Resting blood pressure and cardiovascular reactivity to mental arithmetic in mild hypertensive males supplemented with black currant seed oil. J. Hum. Hypertens. 1996, 10:531-537.
48. Dickerson L.M., Mazyck P.J., Hunter M.H. Premenstrual syndrome. Am. Fam. Physician. 2003, 67:1743-1752.
49. Dinarello C.A. Anti-cytokine strategies. Eur. Cytokine Netw. 1992, 3:7-17.
50. 2 inhibition. Prostaglandins Leukot. Essent. Fatty Acids 1996, 55:159-165.
51. 2 and schizophrenia. Schizophrenia 1998, 31:185-196.
52. Dyerberg J., Bang H.O., Hjome N. Fatty acid composition of the plasma lipids of Greenland Eskimoes. Am. J. Clin. Nutr. 1975, 28:958-966.
53. Engler M.M. Comparative study of diets enriched with evening primrose, black currant, borage or fungal oils on blood pressure and pressor responses in spontaneously hypertensive rats. Prostaglandins Leukot Essent Fatty Acids 1993, 49:809-814.
54. Fan Y-Y., Chapkin R.S. Importance of dietary γ-linolenic acid in human health and nutrition. J. Nutr. 1998, 128:1411-1414.
55. Fan Y-Y., Chapkin R.S., Ramos K.S. Dietary lipid source alters murine macrophage/vascular smooth muscle cell interactions in vitro. J. Nutr 1996, 126:2083-2088.
56. Fearon K.C.H., Falconer J.S., Ross J.A., Carter D.C., Hunter J.O., Reynolds P.D., Tuffnell Q. An open-label phase I/II dose escalation study of the treatment of pancreatic cancer using lithium gammalinolenate. Anticancer Res. 1996, 16:867-874.
57. Fedele D., Giugliano D. Peripheral diabetic neuropathy. Current recommendations and future prospects for its prevention and management. Drugs 1997, 54:414-421.
58. Fewtrell M.S., Abbott R.A., Kennedy K., Singhal A., Morley R., Caine E., Jamieson C., Cockburn F., Lucas A. Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in pre-term infants. J. Pediatr. 2004, 144:471-479.
59. Fievet P., Tribout B., Castier B., Dieval J., Capoid J.C., Delobel J., Coevoet B., Fournier A. Effects of evening primrose oil (EPO) on platelet functions during pregnancy in patients with high risk of toxemia. Kidney Int. 1985, 28:234.
60. Fiocchi A., Sala M., Signoroni P., Banderali G., Agostoni C., Riva E. The efficacy and safety of γ-linolenic acid in the treatment of infantile atopic dermatitis. J. Int. Med. Res. 1994, 22:24-32.
61. Fisher B.A.C., Harbige L.S. Effect of omega-6-lipid rich borage oil feeding on immune function in healthy volunteers. Biochem. Soc. Trans. 1997, 25:343S.
62. Ford I., Cotter M.A., Cameron N.E., Greaves M. The effects of treatment with α-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat. Metabolism. 2001, 50:868-875.
63. Ghasemnezhad A., Cergel S., Honermeier B. Evening primrose oil (EPO) quality changes dependent on storage temperature and storage time. Planta Med. 2006, 72:207.
64. Greenfield S.M., Green A.T., Teare J.P., Jenkins A.P., Punchard N.A., Ainley C.C., Thompson R.P.H. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment. Pharmacol. Ther. 1993, 7:159-166.
65. Guivernau M., Meza N., Barja P., Roman O. Clinical and experimental study on the long-term effect of dietary gamma-linolenic acid on plasma lipids, platelet aggregation, thromboxane formation and prostacyclin production. Prostaglandins Leukot. Essent. Fatty Acids. 1994, 51:311-316.
66. Haimov-Kochman R., Hochner-Celnikier D. Hot flashes revisited: Pharmacological and herbal options for hot flashes management. What does the evidence tell us??. Acta Obstet. Gynecol Scand. 2005, 84:972-979.
67. Halat K.M., Denneby C.E. Botanicals and dietary supplements in diabetic peripheral neuropathy. J. Am. Fam Pract. 2003, 16:47-57.
68. Hamburger M., Riese U., Graf H., Melzig M.F., Ciesielski S., Baumann D., Dittmann K., Wegner C. Constituents in evening primrose oil with radical scavenging, cyclooxygenase and neutrophil elastase inhibitory activities. J. Agric. Food Chem. 2002, 50:5533-5538.
69. Harada T., Hasumi K., Endo A. Induction of low density lipoprotein catabolism in Hep G2 cells by a fungal sesquiterpene ester, FR111142. Biochem. Biophys. Res. Commun. 1998, 251:830-834.
70. Head R.J., McLennan P.L., Raederstorff R., Muggli R, Burnard S.L., McMurchie E.J. Prevention of nerve conduction deficit in diabetic rats by polyunsaturated fatty acids. Am. J. Clin Nutr. 2000, 71(suppl):386S-392S.
71. Hederos C.-A., Berg A. Epogam evening primrose oil treatment in atopic dermatitis and asthma. Arch. Dis. Child 1996, 75:494-497.
72. Henz B.M., Jablonska S., van de Kerkhof P.C.M., Stingl G., Blaszczyk M., Vandervalk P.G.M., Veenhuizen R., Muggli R., Raederstorff D. Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br. J. Dermatol. 1999, 140:685-688.
73. Horrobin D.F. The role of essential fatty acids and prostaglandins in the premenstrual syndrome. J. Reprod Med. 1983, 28:465-468.
74. Horrobin D.F. (1992) The use of gamma-linolenic acid in diabetic neuropathy. Agents Actions Suppl. 1992, 37:120-144.
75. Horrobin D.F. Fatty acid metabolism in health and disease: The role of δ6-desaturase. Am. J. Clin. Nutr. 1993, 57(suppl):732S-737S.
76. Horrobin D.F. The effects of gamma-linolenic acid on breast pain and diabetic neuropathy: Possible non-eicosanoid mechanisms. Prostaglandins Leukot. Essent. Fatty Acids 1993, 48:101-104.
77. Horrobin D.F. Essential fatty acids in the management of impaired nerve function in diabetes. Diabetes 1997, 46(suppl. 2):S90-S93.
78. Horrobin D.F., Manku M.S. How do polyunsaturated acids lower plasma cholesterol levels??. Lipids 1983, 18:558-562.
79. Horrobin D.F., Morse P.F. Evening primrose and atopic eczema. Lancet 1995, 345:260-261.
80. Hounsom L.M., Horrobin D.F., Tritschler H., Corder R., Tomlinson D.R. A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy. Diabetologica 1998, 41:839-843.
81. Humphreys F., Symons J.A., Brown H.K., Duff G.W., Hunter J.A.A. The effects of gamolenic acid on adult atopic eczema and premenstrual exacerbation of eczema. Eur. J. Dermatol. 1994, 4:598-603.
82. Innis S.M., Hansen J.W. Plasma fatty acid responses, metabolic effects and safety of microalgal and fungal oils rich in arachidonic and docosahexaenoic acids in healthy adults. Am. J. Clin. Nutr. 1996, 64:159-167.
83. Ishikawa T., Fujiyama Y., Igarashi O., Morino M., Tada N., Kagami A., Sakamoto T., Nagano M., Nakamura H. Effects of gammalinolenic acid on plasma lipoproteins and apolipoproteins. Artherosclerosis 1989, 75:95-104.
84. Jack A.M., Keegan A., Cotter M.A., Cameron N.E. Effects of diabetes and evening primrose oil treatments on responses of aorta, corpus cavernosum and mesenteric vasculature in rats. Life Sci. 2002, 71:1863-1877.
85. Jamal G.A. The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy. Diabetic Med. 1994, 11:145-149.
86. Jantti J., Seppala E., Vapaatalo H., Isomaki H. Evening primrose oil and olive oil in treatment of rheumatoid arthritis. Clin. Rheumatol. 1989, 8:238-244.
87. Jantti J., Nikkari T., Solakivi T., Vapaatalo H., Isomaki H. Evening primrose oil in rheumatoid arthritis: Changes in serum lipids and fatty acids. Ann. Rheum. Dis. 1989, 48:124-127.
88. Jialal I., Norkus E.P., Cristol L., Grundy S.M. β-Carotene inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta. 1991, 1086:134-138.
89. Jiang W.G., Hiscox S., Horrobin D.F., Bryce R.P., Mansel R.E. Gamma linolenic acid regulates expression of maspin and the motility of cancer cells. Biochem. Biophys. Res. Commun. 1997, 237:639-644.
90. Johansson A., Laakso P., Kallio H. Characterization of seed oils of wild, edible Finnish berries. Z. Lebensm Unters Forsch A. 1997, 204:300-307.
91. Johnston G.A., Bilbao R.M., Graham-Brown R.A.C. The use of dietary manipulation by parents of children with atopic dermatitis. Brit. J. Dermatol. 2004, 150:1186-1189.
92. Kast R.E. Borage oil reduction of rheumatoid arthritis activity may be mediated by increased cAMP that suppresses tumor necrosis factor-alpha. Int. Immunopharm. 2001, 1:2197-2199.
93. Keen H., Payan J., Allawi J., Walker J., Jamal G.A., Weir A.I., Henderson L.M., Bissessar E.A., Watkins P.J., Sampson M., et al. Treatment of diabetic neuropathy with γ-linolenic acid. Diabetes Care 1993, 16:8-15.
94. Khan F., Elherik K., Bolton-Smith C., Barr R., Hill A., Murrie I., Belch J.J.F. The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects. Cardiovasc. Res. 2003, 59:955-962.
95. Khoo S.K., Munro C., Battistutta D. Evening primrose oil and the treatment of premenstrual syndrome. Med. J. Aust. 1990, 153:189-192.
96. Kinsella J.E. α-Linolenic acid: Functions and effects on linoleic acid metabolism and eicosanoid-mediated reactions. Adv. Food Nut. Res. 1991, 35:1-184.
97. Knorr R., Hamburger M. Quantitative analysis of anti-inflammatory and radical scavenging triterpenoid esters in evening primrose oil. J. Agric. Food Chem. 2004, 52:3319-3324.
98. Kollias J., Macmillan R.D., Sibbering D.M., Burrell H., Robertson J.F.R. Effect of evening primrose oil on clinically diagnosed fibroadenomas. The Breast. 2000, 9:35-36.
99. Kronenberg F., Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: A review of randomized, controlled trials. Ann. Intern. Med. 2002, 137:805-813.
100. Kuruvilla R., Peterson R.G., Kincaid J.C., Eichberg J. Evening primrose oil treatment corrects reduced conduction velocity but not depletion of arachidonic acid in nerve from streptozotocin-induced diabetic rats. Prostaglandins Leukot. Essent. Fatty Acids 1998, 59:195-202.
101. Lawson L.D., Hughes B.G. Triacylglycerol structure of plant and fungal oils containing g-linolenic acid. Lipids 1988, 23:313-317.
102. Lehmann B., Hubner C., Jacobi H., Kampf A., Wozel G. Effects of dietary γ-linolenic acid-enriched evening primrose seed oil on the 5-lipoxygenase pathway of neutrophil leukocytes in patients with atopic dermatitis. J. Dermatol. Treat. 1995, 6:211-218.
103. 2 in atopic dermatitis. Br. J. Dermatol. 1997, 136:337-340.
104. Leventhal L.J., Boyce E.G., Zurier R.B. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann. Intern. Med. 1993, 119:867-873.
105. Low Dog T. Menopause: A review of botanical dietary supplements. Am. J. Med. 2005, 118:98S-108S.
106. Lucas A., Morley R., Cole T.J., Lister G., Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born preterm. Lancet 1992, 339:261-264.
107. Manku M.S., Horrobin D.F., Morse N.L., Wright S., Burton J.L. Essential fatty acids in the plasma phospholipids of patients with atopic eczema. Br. J. Dermatol. 1984, 110:643-648.
108. Manku M.S., Morse-Fisher N., Horrobin D.F. Changes in human plasma essential fatty acid levels as a result of administration of linoleic acid and gamma-linolenic acid. Eur. J. Clin. Nutr. 1988, 42:55-60.
109. Mcgregor L., Smith A.D., Sidey M., Belin J., Zilkha K.J., McGregor J.L. Effects of dietary linoleic acid and gamma linolenic acid on platelets of patients with multiple sclerosis. Acta Neurol. Scand. 1989, 80:23-27.
110. McKean M.L., Smith J.B., Silver M.J. Formation of lysophosphatidylcholine by human platelets in response to thrombin. J. Biol. Chem. 1981, 256:1522-1524.
111. Miller L.G. Herbal medicinals. Selected clinical considerations focusing on known or potential drug-herb interactions. Arch. Int. Med. 1998, 158:2200-2211.
112. Mills D.E., Mah M., Ward P.P., Morris B.L., Floras J.S. The effects of stress and dietary n-6 and n-3 rich oils on platelet aggregation in man. Proc ISF/JAOCS World Congress 1989, 1:281-287.
113. Mills D.E., Prkachin K.M., Harvey K.A., Ward R.P. Dietary fatty acid supplementation alters stress reactivity and performance in man. J. Hum. Hypertens. 1989, 3:111-116.
114. Mills D.E., Mah M., Ward R.P., Morris B.L., Floras J.S. Alteration of baroreflex control of forearm vascular resistance by dietary fatty acids. Am J Physiol. 1990, 259:R1164-R1171.
115. Morse N.L., Clough P.M. A meta-analysis of randomized, placebo controlled clinical trials of Efamol® evening primrose oil in atopic eczema. Where do we go from here in light of more recent discoveries??. Curr. Pharmaceut. Biotech. 2006, 7:503-524.
116. Morse P.F., Horrobin D.F., Manku M.S., Stewart J.C.M., Allen R., Littlewood S., Wright S., Burton J., Gould D.J., Holt P.J., et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br. J. Dermatol. 1989, 121:75-90.
117. Nakahara T., Yokochi T., Kamisaka Y., Yamaoka M., Suzuki O., Sato M., Okazaki S., Ohshima N. Inhibitory effect of mold oil including gamma-linolenate on platelet thrombus formation in mesenteric microvessels of the rat. Thromb. Res. 1990, 57:371-381.
118. Parthasarathy S. Novel atherogenic, oxidative modification of low-density lipoprotein. Diabetes Metab. Rev. 1991, 7:163-171.
119. Pellegrina C.D., Padovani G., Mainente F., Zoccatelli G., Bissoli G., Mosconi S., Veneri G., Peruffo A., Andrighetto G., Rizzi C., Chignola R. Anti-tumour potential of a gallic acid-containing phenolic fraction from?. Oenethera biennis. Cancer Letters. 2005, 226:17-25.
120. Peth J.A., Kinnick T.R., Youngblood E.B., Tritschler H.J., Henriksen E.J. Effects of a unique conjugate of α-lipoic acid and γ-linolenic acid on insulin action in obese Zucker rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278:R453-R459.
121. 2 and 5S-HETE. Prost. Leukotr. Ess. Fatty Acids 2006, 74:271-282.
122. Philp H.A. Hot flashes-a review of the literature on alternative and complementary treatment approaches. Altern. Med. Rev. 2003, 8:284-302.
123. Phylactos A.C., Harbige L.S., Crawford M.A. Essential fatty acids alter the activity of manganese-superoxide dismutase in rat heart. Lipids 1994, 29:111-115.
124. Piquette K., Laflamme P. Borage (Borago officinalis) 2000, Alberta Agr., Food and Rural Dev. Library, Edmonton, Alberta.
125. Prichard P., Brown G., Bhasker N., Hawkey C. The effect of dietary fatty acids on gastric production of prostaglandins and aspirin-induced injury. Aliment. Pharmacol. Ther. 1988, 2:179-184.
126. Pullman-Mooar S., Laposata M., Lem D., Holman R.T., Leventhal L.J., DeMarco D., Zurier R.B. Alteration of the cellular fatty acid profile and the production of eicosanoids in human monocytes by gamma-linolenic acid. Arthritis Rheum. 1990, 33:1526-1533.
127. Puri B.K. The clinical advantages of cold pressed, non-raffinated evening primrose oil over refined preparations. Med Hypoth. 2004, 62:116-118.
128. 13C-NMR for the sn-2 positional analysis of triacylglycerols containing γ-linolenic acid. Chem. Phys. Lipids. 1996, 79:9-19.
129. Reljanovic M., Reichel G., Rett K., Lobisch M., Schuette K., Moller W., Tritschler H-J., Mehnert H. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (α-lipoic acid): A two year multicenter randomized double-blind placebo-controlled trial (Aladdin II). Free Radic Res. 1999, 31:171-179.
130. Richard J.-L., Martin C., Maille M., Mendy F., Delplanqe B., Jacotot B. Effects of dietary intake of gamma-linolenic acid on blood lipids and phospholipid fatty acids in healthy human subjects. J. Clin. Biochem. Nutr. 1990, 8:75-84.
131. Rock E., Demichele A. Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors. J. Nutr. 2003, 133:3785S-3793S.
132. Rodgers R.P.C., Levin J. A critical reappraisal of the bleeding time. Semin Thromb. Hemost. 1990, 16:1-20.
133. Schalin-Karrila M., Mattila L., Jansen C.T., Uotila P. Evening primrose oil in the treatment of atopic eczema: Effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins. Br. J. Dermatol. 1987, 117:11-19.
134. Schirmer M.A., Phinney S.D. γ-linolenate reduces weight gain in formerly obese humans. J. Nutr. 2007, 137:1430-1435.
135. Seri S., D'Alessandro A., Acitelli S., Giammaria U., Cocchi M., Noble R.C. Effect of dietary supplementation by alternative oils on blood lipid levels in hemodialysed patients. Med. Sci. Res. 1993, 21:315-316.
136. Shahidi F. Antioxidant factors in plant foods and selected oilseeds. Biofactors. 2000, 13:179-185.
137. Shahidi F., Amarowicz R., He Y., Wettasinghe M. Antioxidant activity of phenolic extracts of evening primrose (Oenothera biennis): A preliminary study. J. Food Lipids. 1997, 4:75-86.
138. Shotton H.R., Clarke S., Lincoln J. The effectiveness of treatments of diabetic autonomic neuropathy is not the same in autonomic nerves supplying different organs. Diabetes 2003, 52:157-164.
139. Simpson M.J.A. Comparison of swathing and desiccation of borage (Borago officinalis) and estimation of optimum harvest stage. Ann. Appl. Biol. 1993, 123:105-108.
140. Spielmann D., Traitler H., Crozier G., Fleith M., Bracco U., Finot P.A., Berger M., Holman R.T. Biochemical and bioclinical aspects of blackcurrant seed oil ω-3 and ω-6 balanced oil. Dietary ω3 and ω6 Fatty Acids: Biological Effects and Nutritional Essentiality 1989, 221-309. Plenum Press, New York. C. Galli, A.P. Simopoulos (Eds.).
141. Stewart J.C.M., Morse P.F., Moss M., Horrobin D.F., Burton J.L., Douglas W.S., Gould D.J., Grattan C.E.H., Hindson T.C., Anderson J., Jansen C.T., Kennedy C.T.C., Lindskov R., Strong A.M.M., Wright S. Treatment of severe and moderately severe atopic dermatitis with evening primrose oil (Epogram): A multi-centre study. J. Nutr. Med. 1991, 2:9-15.
142. Strannegard I.L., Svennerholm L., Strannegard O. Essential fatty acids in serum lecithin of children with atopic dermatitis and in umbilical cord serum of infants with high or low IgE levels. Int .Arch. Allergy Applied Immunol. 1987, 82:422-423.
143. Stroop J.R. Studies of interference in serial verbal reactions. J. Exp. Psychol. 1935, 18:643-662.
144. Sugano M., Ishida T., Yoshida K., Tanaka K., Niwa M., Arima M., Morita A. Effects of mold oil containing y-linolenic acid on blood cholesterol and eicosanoid levels in rats. Agric. Biol. Chem. 1986, 50:2483-2491.
145. Takada R., Saitoh M., Mori T. Dietary γ-linolenic acid-enriched oil reduces body fat content and induces liver enzyme activities relating to fatty acid β-oxidation in rats. J. Nutr. 1994, 124:469-474.
146. Takwale A., Tan E., Agarwal S., Barclay G., Ahmed I., Hotchkiss K., Thompson J.R., Chapman T., Berth-Jones J. Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomized, double blind, placebo controlled parallel group trial. BMJ. 2003, 327:1385-1388.
147. Tamimi N.A.M., Mikhail A., Stevens P.E. Role of γ-linolenic acid in uraemic patients. Nephron 1999, 83:170-171.
148. Tollesson A., Frithz A. Transepidermal water loss and water content in the stratum corneum in infantile seborrhoeic dermatitis. Acta Derm. Venereol. (Stockh.) 1993, 73:18-20.
149. Tollesson A., Frithz A. Borage oil, an effective new treatment for infantile sebborrhoeic dermatitis. Br. J. Dermatol. 1993, 129:95.
150. van der Merwe C.F., Booyens J., Joubert H.F., Masi C.A. The effect of gamma-linolenic acid, an in vitro cytostatic substance contained in evening primrose oil, on primary liver cancer. A double blind placebo-controlled trial. Prostaglandins Leukot Essent Fatty Acids. 1990, 40:199-202.
151. Vericel E., Lagarde M., Mendy F., Courpron P., Dechavanne M. Comparative effects of linoleic acid and gamma-linolenic acid intake on plasma lipids and platelet phospholipids in elderly people. Nutr. Res. 1987, 7:569-580.
152. Viikari J., Lehtonen A. Effect of primrose oil on serum lipids and blood pressure in hyperlipidemic subjects. Int. J. Clin. Pharmacol. Ther. Toxicol. 1986, 24:668-670.
153. Vinik A.I. Diabetic neuropathy: Pathogenesis and therapy. Am. J. Med. 1999, 107:17S-26S.
154. Wagner W., Nootbaar-Wagner U. Prophylactic treatment of migraine with gamma-linolenic acid and alpha-linolenic acids. Cephalagia 1997, 17:127-130.
155. Wainwright P.E., Huang Y-S., DeMichele S.J., Xing H.C., Liu J-W., Chuang L-T., Biederman J. Effects of high-γ-linolenic acid canola oil compared with borage oil on reproduction, growth, and brain and behavioral development in mice. Lipids. 2003, 38:171-178.
156. Watson J., Byars M.L., McGill P., Kelman A.W. Cytokine and prostaglandin production by monocytes of volunteers and rheumatoid arthritis patients treated with dietary supplements of black-currant seed oil. Br. J. Rheumatol. 1993, 32:1055-1058.
157. Werneke U., Earl J., Seydel C., Horn O., Crichton P., Fannon D. Potential health risks of complementary alternative medicines in cancer patients. Brit. J. Cancer. 2004, 90:408-413.
158. Wettasinghe M., Shahidi F., Amarowicz R. Identification and quantification of low molecular weight phenolic antioxidants in the seeds of evening primrose (Oenothera biennis L.)?. J. Agric. Food Chem. 2002, 50:1267-1271.
159. Whelan A.M., Jurgens T.M., Bowles S.K. Natural health products in the prevention and treatment of osteoporosis: systemic review of randomized controlled trials. Ann. Pharmacother. 2006, 40:836-849.
160. Whitaker D.K., Cilliers J., deBeer C. Evening primrose oil (Epogam®) in the treatment of chronic hand dermatitis: Disappointing therapeutic results. Dermatology 1996, 193:115-120.
161. Williams H.C. Evening primrose oil for atopic dermatitis. Brit. Med. J. 2003, 327:1358-1359.
162. Wolever T.M.S. Comments on "treatment of diabetic neuropathy with γ-linolenic acid" by the γ-linolenic multicenter trial group. Diabetes Care 1993, 16:1309-1310.
163. Wright S., Burton J.L. Oral evening-primrose seed oil improves atopic eczema. Lancet 1982, ii:1120-1122.
164. Wu D., Meydani M., Leka L.S., Nightingale Z., Handelman G.J., Blumberg J.B., Meydani S.N. Effect of dietary supplementation with black currant seed oil on the immune response of healthy elderly subjects. Am. J. Clin. Nutr. 1999, 70:536-543.
165. Yoshimoto-Furuie K., Yoshimoto K., Tanaka T., Saima S., Kikuchi Y., Shay J., Horrobin D.F., Hirotoshi E. Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients. Nephron 1999, 81:151-159.
166. Yu K.L., Parry J.W., Zhou K. Fruit seed oils. Nutraceutical and Specialty Lipids and their Co-products Nutraceutical Science and Technology 2006, Vol. 5:86. CRC, Taylor and Francis, New York. F. Shahidi (Ed.).
167. Zaugg J., Potterat O., Plescher A., Honermeier B., Hamburger M. Quantitative analysis of anti-inflammatory and radical scavenging triterpenoid esters in evening primrose seeds. J. Agric. Food Chem. 2006, 54:6623-6628.
168. Zhu M., Zhou P.P., Yu L.J. Extraction of lipids from Mortiella alpina and enrichment of arachidonic acid from fungal lipids. Biores. Tech. 2002, 84:93-95.
169. Ziboh V.A. The significance of polyunsaturated fatty acids in cutaneous biology. Lipids 1996, 31(suppl):S249-S253.
170. 4. Am. J. Clin. Nutr. 1992, 55:39-45.
171. 4 generation by ex-vivo neutrophils isolated from asthma patients on dietary supplementation with gammalinolenic acid-containing borage oil: Possible implication in asthma. Clin. Dev. Immunol. 2004, 11:13-21.
172. Zurier R.B., Rossetti R.G., Jacobsen E.W., DeMarco D.M., Liu N.Y., Temming J.E., White B.M., LaPosata M. Gamma-linolenic acid treatment of rheumatoid arthritis. A randomized placebo-controlled study. Arthritis Rheum. 1996, 39:1808-1817.